Korea Tobacco and Ginseng Corp. acquired Yungjin.

Published: 2003-08-18 06:58:00

Updated: 2003-08-18 06:58:00

KT&G announced on Aug. 12 in the board of director's meeting that they decided to invest 14.6 billion won for an acquisition of Yungjin pharmaceutical company for the purpose of building up the basic foundation of the future bio-science industrial development.

The KT&G's acquisition of Yungjin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK